|
Wednesday, November 16, 2022
Print Current Session:
 |
|
|
Wednesday
SESSION 26:
NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs) AND DRUG ELUTING STENTS (DESs): UPDATES ON RANDOMIZED CONTROLLED TRIALS (RCTs) AND BTK LESION TREATMENTS WITH DCBs AND DESs
|
|
| SESSION 26 SCHEDULE | |
| NEW INFORMATION ON DCBs AND DESs FOR FEMPOP LESIONS: UPDATES ON RCTs | |
| 10:18 AM - 10:23 AM | Cost Effectiveness Analysis Of Drug Eluting Technologies For Femoropopliteal Lesions Show That They Are Worth The Increased Device Costs |
|
Presenter(s):Stefan Mueller-Huelsbeck, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:24 AM - 10:29 AM | Stellarex (Philips) DCBs With Low Dose Paclitaxel Is Safe And Has Higher Patency Rates Than POBA With Fempop Lesions At 5 Years In The ILLUMENATE US And European RCTs: There Was No Paclitaxel Mortality Signal |
|
Presenter(s):Sean P. Lyden, MD / Marianne Brodmann, MD / Sahil A. Parikh, MD / William A. Gray, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:30 AM - 10:35 AM | Pooled Data From The In.Pact RCT And Real World DCB Trials For SFA-Pop Lesions Show Safety And Efficacy For 5 Years Compared To POBA: Will The Advantage Of DCBs Diminish With Time |
|
Presenter(s):Peter A. Schneider, MD / John R. Laird, MD / Thomas Zeller, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:36 AM - 10:41 AM | New Findings From The DRASTICO Study Comparing DESs To DCBs For Fempop Lesions: 5-Year Results With TASC A/B Lesions Versus TASC C/D Lesions |
|
Presenter(s):Francesco Liistro, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:42 AM - 10:47 AM | Value Of In.Pact DCBs For Long Complex SFA-Pop Lesions Including ISR And CTOs: Technical Tips And Contraindications: From The Global Registry: What Is The Best Endo Treatment For These Lesions |
|
Presenter(s):Gunnar Tepe, MD / Marianne Brodmann, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:48 AM - 10:53 AM | Update On The Randomized Head To Head Comparison Of In.Pact (Medtronic) And Ranger (Boston Scientific) DCBs For Complex SFA Lesions: 2-Year Results Of The COMPARE RCT: Similar Results With Different Paclitaxel Dosages |
|
Presenter(s):Dierk Scheinert, MD / Sabine Steiner, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:54 AM - 10:59 AM Power Point Presentation with Synched Audio |
Update On The Global RANGER II RCT Comparing Ranger DCBs With POBA: How Does It Help Us Determine The Best Treatment For Long Complex ATK Lesions |
|
Presenter(s):Marianne Brodmann, MD Location: Grand Ballroom East, 3rd Floor |
|
| 11:00 AM - 11:05 AM | New Information On The Safety And Effectiveness Of The Cook Zilver PTX DES Based On Global Trials Including A RCT: When Is It The Best Treatment |
|
Presenter(s):Michael D. Dake, MD Location: Grand Ballroom East, 3rd Floor |
|
| 11:06 AM - 11:11 AM | 2-Year Results Of The IMPERIAL RCT Head To Head Comparison Of The Zilver PTX DES (Cook) With The Eluvia DES (Boston Scientific): Both Are Safe And Effective: Is There A Difference |
|
Presenter(s):Stefan Mueller-Huelsbeck, MD / William A. Gray, MD / Thomas Zeller, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:12 AM - 11:18 AM | Panel Discussion |
| NEW INFORMATION ON BTK DCBs AND DESs | |
| 11:18 AM - 11:23 AM | Advances In BTK Drug Delivery Technology And DCBs: What Have We Learned From The In.Pact Deep BTK DCB Trial And New Challenges With Treating CLTI Patients |
|
Presenter(s):Thomas Zeller, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:24 AM - 11:29 AM | The Sirolimus DCB BTK Era Begins – Current Experience With The Selution DEB And Design Of The SELUTION SLR .014 BTK IDE Trial: Early Results From Singapore And Europe |
|
Presenter(s):Patrick J. Geraghty, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:30 AM - 11:35 AM | Orbital Vessel Preparation To Maximize DCB Efficacy In Calcified BTK Lesions: OPTIMIZE BTK RCT 1-Year Results |
|
Presenter(s):Thomas Zeller, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:36 AM - 11:41 AM Power Point Presentation with Synched Audio |
3-Year Results From The AcoArt II BTK DCB RCT Show Safety With No Increased Mortality And Improved Patency Versus POBA |
|
Presenter(s):Wei Guo, MD / Francesco Liistro, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:42 AM - 11:47 AM | Why Some BTK DCB Trials Have Not Shown Uniformly Better Results: Technical And Balloon Factors Matter |
|
Presenter(s):Francesco Liistro, MD Location: Grand Ballroom East, 3rd Floor |
|
| 11:48 AM - 11:53 AM | Update On The SAVAL Trial With A Self-Expanding DES (From Boston Scientific) For BTK Occlusive Lesions |
|
Presenter(s):Miguel F. Montero, MD / Jihad A. Mustapha, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:54 AM - 12:00 PM | Panel Discussion |
| 12:00 PM - 1:00 PM | Lunch Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 26 | |
| previous | next |